EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://imux.com/wp-content/uploads/2021/07/20201020_EIB_supports_Immunic_EN_final.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts: